Metri Bio CEO Ashley Abel Selected for the 2026 Termeer Fellowship

Metri Bio CEO and co-founder Ashley Abel has been selected for the 2026 Termeer Fellowship, a highly competitive leadership program for emerging life sciences CEOs. Through mentorship, peer learning, and access to an experienced network of biotechnology leaders, the fellowship supports founders as they scale companies working to address major unmet needs in healthcare. Ashley joins a select cohort of leaders shaping the next generation of life sciences innovation.

Our mission

Metri Bio is working to radically improve the lives of people suffering from endometriosis and uterine diseases.